Diabetic Peripheral Neuropathy: Foot Care 2026 | DPM

Neuropathy Type	Fiber Type Affected	Symptoms	Exam Finding	Risk Level
Small Fiber Neuropathy	C and A-delta fibers (pain/temperature)	Burning; shooting; allodynia; early diabetic neuropathy	Reduced pinprick; thermal discrimination; normal vibration	High pain burden; preserved protective sensation possible
Large Fiber Neuropathy	A-beta fibers (vibration/proprioception)	Numbness; imbalance; reduced proprioception; painless	Absent vibration (>10 sec 128Hz tuning fork); abnormal monofilament	HIGHEST ulcer risk — loss of protective sensation (LOPS)
Autonomic Neuropathy	Autonomic C-fibers	Dry skin; fissuring; absent sweating; erectile dysfunction; orthostatic hypotension	Dry cracked skin; absent hair; dependent edema	Skin breakdown risk; Charcot foot risk
Mixed (Most Diabetic Patients)	All fiber types	Combination of above	Multiple modality deficits	Very high — comprehensive foot surveillance required

Intervention	Target	Mechanism	Evidence	Notes
Glycemic Control (HbA1c <7%)	Prevention / slowing progression	Reduces advanced glycation end-products; reduces nerve ischemia	Level I — DCCT trial: 60% reduction in neuropathy progression	Most powerful intervention available
Pregabalin / Gabapentin	Neuropathic pain	Alpha-2-delta calcium channel subunit blockade; reduces neuronal excitability	Level I — FDA-approved for DPN pain	Start low; titrate; sedation and weight gain common
Duloxetine (Cymbalta)	Neuropathic pain	SNRI; inhibits pain signal transmission	Level I — FDA-approved for DPN pain	30-60mg; also treats comorbid depression
Topical Capsaicin / Lidocaine	Localized neuropathic pain	TRPV1 desensitization (capsaicin); local sodium channel block (lidocaine)	Level II — adjunctive only	No systemic effects; useful for localized burning
Diabetic Footwear (extra-depth + orthotics)	Ulcer prevention	Accommodates deformity; reduces plantar pressure; eliminates friction	Level I — reduces ulcer risk 50-60% in high-risk patients	Medicare Part B covers for eligible diabetic patients

Quick answer: Diabetic Peripheral Neuropathy Foot Care Prevention is a common foot/ankle topic that affects many patients. The 2026 evidence-based approach combines proper diagnosis, conservative-first treatment, and escalation only when needed. We treat this regularly at our Howell and Bloomfield Hills practices. Call (810) 206-1402.

https://www.youtube.com/watch?v=8opvH3qxkW4

How Diabetic Neuropathy Threatens Your Feet

Diabetic peripheral neuropathy (DPN) is nerve damage caused by chronically elevated blood glucose that affects the longest nerves first — those reaching the feet and lower legs. Over time, DPN produces a “stocking” distribution of numbness, tingling, or burning that gradually abolishes protective pain sensation. Without the ability to feel a blister, a cut, or abnormal pressure, small injuries escalate silently into ulcers, deep tissue infection, and potentially limb-threatening conditions. Approximately 15–25% of diabetics will develop a foot ulcer in their lifetime, and 80% of lower extremity amputations in the United States are preceded by a diabetic foot ulcer.

Types of Diabetic Neuropathy Affecting the Feet

Sensory neuropathy is the most familiar form — progressive loss of vibration, temperature, and pain sensation. Motor neuropathy weakens the intrinsic foot muscles, causing digital contractures (hammer toes, claw toes) that create new pressure points. Autonomic neuropathy reduces sweating, causing abnormally dry, fissured skin vulnerable to bacterial and fungal invasion. All three neuropathy subtypes commonly coexist in longstanding diabetes, creating a compounding vulnerability that demands comprehensive management.

Annual Diabetic Foot Exam at Balance Foot & Ankle

Every diabetic patient should receive a comprehensive foot examination at least annually — more frequently if neuropathy or vascular disease is present. Dr. Biernacki’s diabetic foot exam includes Semmes-Weinstein monofilament testing (identifying loss of protective sensation), vibration testing with a 128 Hz tuning fork, ankle-brachial index (ABI) measurement for vascular assessment, skin and nail evaluation, biomechanical assessment for high-pressure areas, and ulcer risk stratification using the Wagner or University of Texas grading systems.

Daily Foot Care Protocol for Diabetics

Every diabetic patient with neuropathy should inspect both feet daily — top, bottom, between toes, and heel — using a mirror for the sole if needed. Wash feet daily with lukewarm (never hot) water, dry thoroughly between toes, and apply moisturizer to the heel and sole (never between the toes). Trim nails straight across at or just below the end of the toe. Never go barefoot indoors or outdoors. Shake shoes before putting them on to check for foreign objects. Replace shoes regularly and avoid tight-fitting footwear.

Diabetic Footwear and Medicare Coverage

Medicare and most major insurance plans cover therapeutic diabetic shoes and custom-molded inserts under the Therapeutic Shoe Bill for patients with diabetes and certain qualifying conditions. Properly fitting diabetic shoes — with a wide toe box, seamless interior, depth design, and minimal heel height — dramatically reduce ulcer risk. Dr. Biernacki is a qualified prescriber for therapeutic diabetic footwear and can coordinate prescription and fitting through our office.

Dr. Tom's Product Recommendations

What is Neuropathy?

Neuropathy is a common foot/ankle condition that affects mobility and quality of life. Understanding the underlying cause is the first step in successful treatment. Our podiatrists at Balance Foot & Ankle perform a hands-on biomechanical exam, review your activity history, and use diagnostic imaging when appropriate to identify the root cause—not just treat the symptom. Many patients have been told to “rest and ice” without a deeper diagnostic workup; our approach is different.

Symptoms and warning signs

Common signs of neuropathy include pain that worsens with activity, morning stiffness, swelling, tenderness when palpated, and difficulty bearing weight. If you experience sudden severe pain, inability to walk, visible deformity, numbness or color change, contact our office the same day or visit urgent care—these can signal a more serious injury such as a fracture, tendon rupture, or vascular compromise. Diabetics with any foot wound should seek same-day care.

Conservative treatment options

Most cases of neuropathy respond to non-surgical care: structured rest, supportive footwear changes, custom orthotics, targeted stretching and strengthening protocols, anti-inflammatory medications when medically appropriate, and in-office procedures such as ultrasound-guided injections. We also offer advanced therapies including MLS laser therapy, EPAT/shockwave, regenerative injections, and image-guided procedures. Treatment is sequenced from least invasive to most invasive, and we explain the rationale at every step.

When is surgery considered?

Surgery is reserved for cases that fail 3-6 months of well-structured conservative care, when there is structural pathology (severe deformity, complete tear, advanced arthritis), or when imaging shows damage that will not heal without intervention. Our surgeons have performed 3,000+ foot and ankle procedures and prioritize minimally-invasive techniques whenever appropriate. We discuss recovery timelines, return-to-activity milestones, and realistic outcome expectations before any procedure is scheduled.

Recovery timeline and prevention

Recovery from neuropathy varies based on severity and chosen treatment path. Conservative cases often improve within 4-8 weeks with consistent adherence to the protocol. Post-procedural recovery may range from a few days (in-office procedures) to several months (reconstructive surgery). Long-term prevention involves footwear assessment, activity modification, structured strengthening, and regular check-ins with your podiatrist if you have a history of recurrence. We provide written home-exercise plans and digital follow-up support.

American Podiatric Medical Association: Neuropathy